Disseminated histoplasmosis in a heart transplant recipient from Saudi Arabia: A case report

J Infect Public Health. 2021 Aug;14(8):1013-1017. doi: 10.1016/j.jiph.2021.05.012. Epub 2021 May 27.

Abstract

Histoplasma is endemic in North and Central America. We describe a case of disseminated histoplasmosis in a heart transplant recipient outside the known endemic areas. A 68-year-old gentleman known to have dilated cardiomyopathy. He underwent left ventricular assist device (LVAD) implantation in India and 2 years later did heart transplant in King Faisal Specialist and Research Center Hospital. Six weeks post-transplant he presented with headache and fever. All investigations were negative, and he was discharged home. Four days after discharge he presented with headache, fever, blurred vision, and an episode of loss of consciousness. Examination showed an ill looking patient who is highly febrile. Repeated work up showed pancytopenia. A repeat LP was negative. Bone marrow biopsy showed Small intracellular organisms. Extended work up revealed a positive Histoplasma urinary antigen, positive Histoplasma PCR from the bone marrow biopsy. Patient was started on Liposomal Amphotericin followed by Itraconazole with marker clinical improvement. This is the first reported case of disseminated Histoplasmosis in Saudi Arabia. We postulate that the patient had reactivation of a latent infection acquired at the time of LVAD insertion in India rather than donor derived infection by the negative fungal culture and PCR done on the donor's lung granuloma tissue.

Keywords: Disseminated; Fungi; Histoplasmosis; Transplant.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antifungal Agents / therapeutic use
  • Heart Transplantation* / adverse effects
  • Histoplasmosis* / diagnosis
  • Histoplasmosis* / drug therapy
  • Humans
  • India
  • Male
  • Saudi Arabia

Substances

  • Antifungal Agents